Page 64 - Clinical-Medical Solution for Clinical Chemistry
P. 64

Application  No.C142$
    News

            MRM parameter:
                                                                   Q3       Q3    Ret. Time   CE       CE
               #               Name             Polarity  Q1
                                                                Qualifier 1  Qualifier 2  (min)  Qualifier 1  Qualifier 1
               1   Meldonium                      +       147.20    58.25    59.25     8.18      -27      -18
               2   Etilefrine                     +       182.30   135.25    91.25     5.34      -20      -27
               3   Norfenefrine                   +       154.20    91.25    65.25     6.01      -21      -35
               4   Octopamine                     +       154.20    91.25   119.20     6.00      -21      -15
               5   Oxilofrine                     +       182.30   149.25   105.25     5.69      -20      -22
               6   Synefrine                      +       168.20   135.20   107.25     5.87      -20      -31
               7   Meldonium-d3                   +       150.20    62.25    60.25     8.18      -18      -30
               8   Etilefrine sulphate            +       262.20   164.15              5.19      -19
               9   Synefrine sulphate             +       248.20   150.25   135.20     5.68      -15      -30
               10  Norfenefrine sulphate          +       234.20   136.20    91.20     5.62      -18      -35
               11  Etilefrine sulphate_neg        -       260.20   180.20   121.10     5.19      18       39
               12  Oxilofrine sulphate_neg        -       260.20    77.10   178.20     5.49      26       12
               13  Synefrine sulphate_neg         -       246.20   148.20   106.10     5.70      20       30
               14  Norfenefrine sulphate_neg      -       232.20   152.20   121.15     5.69      17       36
               15  Octopamine sulphate_neg        -       232.20   134.15   107.10     5.81      22       30
            #7     : Internal Standard
            #8 ʙ 15  : Confirmation of Sulpho-conjugate
            Compound list including MRM transitions for unchanged parent drug molecules and corresponding sulfonated
            metabolites. Rapid polarity switching was used during the analysis to confirm peak identification.



              Trap                                              Analysis

                         Trap column
                    Waste
                             2 1                                               2 1
              Pump A
                                           Pump C
                            3   6                                             3   6
                             4 5                                               45
                                   Analytical
                                    column

              Pump B


                                              Fig. 2  Flow Diagram of 2D-HILIC System

            Diluted urine samples were injected directly onto the
                                                                      FCV (1-2)        FCV (1-6)
            2D HILIC system using a HILIC trapping column for   B Conc. (%)                         Flow (mL/min)
            clean-up and pre-concentration followed by an           100    B Conc.
            effective HILIC analytical separation.                                                   0.3
                                                                         Pump A/B Flow
                                                                     50                              0.2
                                                                                                     0.1
                                                                         Pump C Flow
                                                                      0     4.0   8.0  12.0  16.0  18.0
                                                                        Fig. 3  Flow Rate and Gradient Program

            Q Sample Preparation of Urine Sample
            1. Centrifuge urine samples at 3,000 rpm for 10 min at room temperature.
            2. Transfer 60 μL supernatant to new tube and add 10 μL IS solution (*) and 140 μL acetonitrile, mix the solution by
               vortex mixing.
            3. Centrifuge at 13,000 rpm for 5 min.
            4. Transfer 180 μL supernatant to vial.
               (*) Meldonium-d3 in 200 mM Ammonium Acetate
   59   60   61   62   63   64   65   66   67   68   69